Related Experiment Video
Updated: Jul 15, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Natriuretic peptides and therapeutic applications
Candace Y W Lee1, John C Burnett
1Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55906, USA. lee.candace@mayo.edu
Heart Failure Reviews
|April 19, 2007
Summary
Natriuretic peptides (NPs) are heart hormones crucial for managing heart failure. This review explores their therapeutic uses in acute heart failure and future research directions.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Pharmacology
Background:
- Natriuretic peptides (NPs) are endogenous hormones released by the heart in response to stretch.
- Key mammalian NPs include atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP).
- The NP system plays a vital role in compensating for neurohumoral activation in heart failure.
Purpose of the Study:
- To review the therapeutic applications of natriuretic peptides in acute heart failure syndromes.
- To discuss emerging therapeutic agents and future research avenues in NP-based therapies.
Main Methods:
- Literature review of physiological, diagnostic, and therapeutic roles of NPs.
- Analysis of NP system mechanisms, including receptor binding and downstream effects.
- Synthesis of current and future therapeutic strategies involving NPs.
Main Results:
- NPs mediate natriuresis, vasodilation, and anti-remodeling effects via natriuretic peptide receptor A (NPR-A) activation.
- The NP system acts as a compensatory mechanism against heart failure progression.
- Exogenous NPs offer a therapeutic rationale for managing acutely decompensated heart failure.
Conclusions:
- Natriuretic peptides are essential in cardiovascular homeostasis and heart failure management.
- Therapeutic applications of NPs in acute heart failure are well-established.
- Ongoing research promises novel NP-based treatments for cardiovascular diseases.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...